Eisai Satisfies All-Case Surveillance Requirement for Anticancer Agent Remitoro
Go back to Eisai Satisfies All-Case Surveillance Requirement for Anticancer Agent Remitoro| (AMEX: ESAIY) | Delayed: 7.46 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.46 | 52 Week High | $ | |||
| Open | $7.46 | 52 Week Low | $ | |||
| Day High | $7.46 | P/E | N/A | |||
| Day Low | $7.46 | EPS | $ | |||
| Volume | 148,461 | |||||
| Eisai Co Ltd (AMEX: ESALF) | Delayed: 31.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.00 | 52 Week High | $66.25 | |||
| Open | $31.00 | 52 Week Low | $53.50 | |||
| Day High | $31.00 | P/E | N/A | |||
| Day Low | $31.00 | EPS | $0.00 | |||
| Volume | 1 | |||||
